Internal Medicine, Cardiovascular Disease · Rancho Mirage, CA
NPI
1104887447
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
39000 Bob Hope Dr, Emc - Wallis Bldg.
Rancho Mirage, CA, 92270
Phone (760) 346-0642
Groups this clinician bills Medicare through
Medicare paid, 2024
$622K
18,344 services
Medicare patients, 2024
2,630
Average age 78
Drug cost, 2024
$3.7M
10,920 prescriptions
Company payments, 2025
$1,403
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip J Patel was code 99457 (e&m - miscellaneous), 6,038 times for 765 patients. In total Philip J Patel billed 18,344 services in 93 codes, and Medicare paid $622K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99457 E&M - Miscellaneous | Facility | 6,038 | 765 | $22.56 | $136K |
| 93010 Electrocardiogram | Facility | 1,910 | 1,625 | $6.15 | $12K |
| 99214 Office E&M - Established | Facility | 1,198 | 883 | $74.14 | $89K |
| 93306 Echocardiography (TTE/TEE) | Facility | 890 | 831 | $52.22 | $46K |
| 76376 CT Scan | Facility | 809 | 768 | $8.42 | $6,810 |
| 99211 Office E&M - Established | Facility | 635 | 434 | $6.29 | $3,993 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 568 | 510 | $13.31 | $7,560 |
| 93016 Electrocardiogram | Facility | 530 | 528 | $16.33 | $8,657 |
| 93018 Electrocardiogram | Facility | 530 | 528 | $10.78 | $5,711 |
| 99215 Office E&M - Established | Facility | 491 | 334 | $108.64 | $53K |
| 78452 Myocardial Perfusion Scan | Facility | 487 | 486 | $58.56 | $29K |
| G0422 Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 424 | 23 | $105.37 | $45K |
| G0423 Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | Office | 403 | 23 | $105.60 | $43K |
| 99458 E&M - Miscellaneous | Facility | 375 | 250 | $22.22 | $8,334 |
| 93294 External Electrocardiographic Monitoring | Facility | 309 | 98 | $21.85 | $6,751 |
By year: 2022 $696K for 21,865 services; 2023 $614K for 18,624 services; 2024 $622K for 18,344 services.
Medicare prescription drug claims, 2024
In 2024, the drug Philip J Patel prescribed most often to Medicare patients was Atorvastatin Calcium, with 853 prescriptions and refills. In total Philip J Patel wrote 10,920 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 853 | 2,447 | 275 | $9,067 |
| Carvedilol Generic | 644 | 1,817 | 211 | $7,471 |
| Ezetimibe Generic | 642 | 1,857 | 207 | $23K |
| Rosuvastatin Calcium Generic | 608 | 1,760 | 207 | $10K |
| Spironolactone Generic | 503 | 1,436 | 174 | $5,985 |
| Amlodipine Besylate Generic | 469 | 1,373 | 165 | $3,811 |
| Jardiance Empagliflozin | 424 | 1,067 | 135 | $603K |
| Eliquis Apixaban | 370 | 878 | 98 | $497K |
| Potassium Chloride Generic | 316 | 837 | 127 | $9,608 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 297 | 817 | 91 | $17K |
| Losartan Potassium Generic | 287 | 832 | 102 | $3,094 |
| Repatha Sureclick Evolocumab | 276 | 591 | 77 | $324K |
| Xarelto Rivaroxaban | 264 | 700 | 93 | $381K |
| Metoprolol Tartrate Generic | 245 | 385 | 167 | $657 |
| Valsartan Generic | 244 | 707 | 87 | $9,971 |
Brand drugs: - claims; generic drugs: 8,820 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Philip J Patel $1,403 ($1,403 in general payments such as food, travel and fees) from 9 companies. The largest payer was Boston Scientific Corporation with $678.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 32 | $678 |
| Edwards Lifesciences Corporation EW | 1 | $178 |
| Abbott Laboratories ABT | 6 | $146 |
| BridgeBio Pharma, Inc. BBIO | 1 | $135 |
| Stryker Corporation SYK | 1 | $123 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $61.58 |
| Medtronic, Inc. MDT | 1 | $38.51 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $21.78 |
| Pfizer Inc. PFE | 1 | $21.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.